330 related articles for article (PubMed ID: 11867823)
1. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.
Wolter J; Seeney S; Bell S; Bowler S; Masel P; McCormack J
Thorax; 2002 Mar; 57(3):212-6. PubMed ID: 11867823
[TBL] [Abstract][Full Text] [Related]
2. Long term azithromycin therapy in patients with cystic fibrosis.
Emiralioğlu N; Öztürk Z; Yalçın E; Doğru D; Özçelik U; Kiper N
Turk J Pediatr; 2016; 58(1):34-40. PubMed ID: 27922234
[TBL] [Abstract][Full Text] [Related]
3. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
[TBL] [Abstract][Full Text] [Related]
4. [Azithromycin therapy in cystic fibrosis].
Máiz Carro L; Cantón Moreno R
Med Clin (Barc); 2004 Mar; 122(8):311-6. PubMed ID: 15030744
[TBL] [Abstract][Full Text] [Related]
5. Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial.
Clement A; Tamalet A; Leroux E; Ravilly S; Fauroux B; Jais JP
Thorax; 2006 Oct; 61(10):895-902. PubMed ID: 16809416
[TBL] [Abstract][Full Text] [Related]
6. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
[TBL] [Abstract][Full Text] [Related]
7. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Anstead M; Mayer-Hamblett N; Lands LC; Kloster M; Hocevar-Trnka J; Goss CH; Rose LM; Burns JL; Marshall BC; Ratjen F;
JAMA; 2010 May; 303(17):1707-15. PubMed ID: 20442386
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
Saiman L; Marshall BC; Mayer-Hamblett N; Burns JL; Quittner AL; Cibene DA; Coquillette S; Fieberg AY; Accurso FJ; Campbell PW;
JAMA; 2003 Oct; 290(13):1749-56. PubMed ID: 14519709
[TBL] [Abstract][Full Text] [Related]
9. Improved lung function and body mass index associated with long-term use of Macrolide antibiotics.
Pirzada OM; McGaw J; Taylor CJ; Everard ML
J Cyst Fibros; 2003 Jun; 2(2):69-71. PubMed ID: 15463852
[TBL] [Abstract][Full Text] [Related]
10. Long-term daily high and low doses of azithromycin in children with cystic fibrosis: a randomized controlled trial.
Kabra SK; Pawaiya R; Lodha R; Kapil A; Kabra M; Vani AS; Agarwal G; Shastri SS
J Cyst Fibros; 2010 Jan; 9(1):17-23. PubMed ID: 19818694
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of azithromycin in plasma, blood, polymorphonuclear neutrophils and sputum during long-term therapy in patients with cystic fibrosis.
Wilms EB; Touw DJ; Heijerman HG
Ther Drug Monit; 2006 Apr; 28(2):219-25. PubMed ID: 16628134
[TBL] [Abstract][Full Text] [Related]
12. Long term azithromycin therapy in cystic fibrosis patients: a study on drug levels and sputum properties.
Baumann U; King M; App EM; Tai S; König A; Fischer JJ; Zimmermann T; Sextro W; von der Hardt H
Can Respir J; 2004 Mar; 11(2):151-5. PubMed ID: 15045047
[TBL] [Abstract][Full Text] [Related]
13. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged use of azithromycin in patients with cystic fibrosis: a meta-analysis.
Florescu DF; Murphy PJ; Kalil AC
Pulm Pharmacol Ther; 2009 Dec; 22(6):467-72. PubMed ID: 19328860
[TBL] [Abstract][Full Text] [Related]
15. Sputum bacterial load and bacterial composition correlate with lung function and are altered by long-term azithromycin treatment in children with HIV-associated chronic lung disease.
Abotsi RE; Dube FS; Rehman AM; Claassen-Weitz S; Xia Y; Simms V; Mwaikono KS; Gardner-Lubbe S; McHugh G; Ngwira LG; Kwambana-Adams B; Heyderman RS; Odland JØ; Ferrand RA; Nicol MP;
Microbiome; 2023 Feb; 11(1):29. PubMed ID: 36803868
[TBL] [Abstract][Full Text] [Related]
16. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial.
Equi A; Balfour-Lynn IM; Bush A; Rosenthal M
Lancet; 2002 Sep; 360(9338):978-84. PubMed ID: 12383667
[TBL] [Abstract][Full Text] [Related]
17. Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.
Cogen JD; Faino AV; Onchiri F; Gibson RL; Hoffman LR; Kronman MP; Rosenfeld M; Nichols DP
Ann Am Thorac Soc; 2021 Feb; 18(2):266-272. PubMed ID: 32810412
[No Abstract] [Full Text] [Related]
18. Daily versus weekly azithromycin in cystic fibrosis patients.
McCormack J; Bell S; Senini S; Walmsley K; Patel K; Wainwright C; Serisier D; Harris M; Bowler S
Eur Respir J; 2007 Sep; 30(3):487-95. PubMed ID: 17537764
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of treatment response to azithromycin in patients with cystic fibrosis.
Saiman L; Mayer-Hamblett N; Campbell P; Marshall BC;
Am J Respir Crit Care Med; 2005 Oct; 172(8):1008-12. PubMed ID: 16040785
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against bactericidal/permeability-increasing protein (BPI-ANCA) in cystic fibrosis patients treated with azithromycin.
Rotschild M; Elias N; Berkowitz D; Pollak S; Shinawi M; Beck R; Bentur L
Clin Exp Med; 2005 Jul; 5(2):80-5. PubMed ID: 16096858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
